Futura Medical plc (FUM) Ordinary GBP0.02
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Futura Medical reports progress with R&D pipeline
4 November 2024 14:21
(Sharecast News) - Futura Medical announced encouraging progress in its product development pipeline on Monday, with successful proof-of-concept results for two new treatments addressing sexual dysfunction.
-
Futura Medical due $5m milestone payment from Haleon
7 October 2024 14:17
(Sharecast News) - Futura Medical, the consumer healthcare company behind Eroxon, announced on Monday that a $5m milestone payment had been triggered under its agreement with consumer products giant Haleon.
-
Futura has 'transformational year' in 2023
6 February 2024 10:08
(Sharecast News) - Consumer healthcare company Futura said on Tuesday that 2023 had been a "transformational year", with the group generating its first meaningful revenues and laying the...
-
Futura Medical extends agreement with Cooper Consumer Health
15 January 2024 14:59
(Sharecast News) - Sexual health product developer Futura Medical announced an extension of its exclusive licensing agreement with Cooper Consumer Health on Monday.
-
Futura Medical wins European patent for erectile dysfunction gel
2 October 2023 14:22
(Sharecast News) - Sexual health specialist Futura Medical announced the successful acquisition of an EU patent for its MED3000 topical erectile dysfunction product on Monday.
-
Futura Medical shares rise on ED licensing deal with Haleon
17 July 2023 08:33
(Sharecast News) - Shares in Futura Medical gained on Monday after the company said it signed a licensing deal with consumer heath care giant Haleon for the rights to exclusively commercialise its topical,...
-
Futura's erection gel launched over-the-counter in the UK
18 April 2023 13:09
(Sharecast News) - Sexual health-focussed pharmaceutical company Futura Medical announced on Tuesday that its topical gel formulation for the treatment of erectile dysfunction (ED), MED3000, is now available...
-
Futura gearing up for US approval, launches of erection gel
13 December 2022 12:51
(Sharecast News) - Drug delivery technology developer Futura Medical updated the market on the regulatory progress and recent commercial activities for its 'MED3000' topical gel treatment for...
-
Futura Medical completes FDA work for erectile treatment
3 October 2022 13:13
(Sharecast News) - Futura Medical has completed the work required for the FDA to grant marketing authorisation for 'MED3000', its fast acting clinically proven treatment for erectile dysfunction,...
-
Futura signs up Korean partner for erection gel product
23 March 2022 15:35
(Sharecast News) - Pharmaceutical and drug delivery technology developer Futura Medical has entered into a licensing agreement with Menarini Korea, it announced on Wednesday, for the exclusive rights to...
Company announcements Announcements
-
Holding(s) in Company
20 December 2024 07:58
Futura Medical
-
Block Listing Six Monthly Return
2 December 2024 07:00
Futura Medical
-
TR-1: Notification of major holdings
15 November 2024 07:00
Futura Medical
-
Encouraging New Product Development Pipeline
4 November 2024 07:00
Futura Medical
-
Total Voting Rights
31 October 2024 07:00
Futura Medical
-
Further milestone payment triggered post US launch
7 October 2024 07:00
Futura Medical
-
Total Voting Rights
1 October 2024 07:00
Futura Medical
-
Directors’ / PDMR Dealing
13 September 2024 07:00
Futura Medical
-
Trinity Delta research note & consensus forecasts
11 September 2024 17:43
Futura Medical
-
Futura Medical - Interim Results 2024
10 September 2024 07:00
Futura Medical
-
Update on US Launch
2 September 2024 10:47
Futura Medical
-
Update on US launch
2 September 2024 07:00
Futura Medical
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.